Colesevelam hydrochloride appears to be an effective lipid-lowering agent that significantly reduces low-density lipoprotein (LDL) cholesterol levels, according to a study published in the October issue of Mayo Clinic Proceedings.
Twenty-five of every 100 U.S. children are either overweight or obese, but children from other major nations are beginning to weigh too much as well, a new University of North Carolina at Chapel Hill study concludes. Sixteen percent of Russian youths are overweight or downright fat, and the figure for Chinese children is 7 percent.
A study by Liu et al. strengthens the evidence that glycemic load, a measure of carbohydrate intake, can predict cardiovascular disease (CVD) risk, especially in those who are insulin resistant.
While GPs’ understanding of the definition of insulin resistance is excellent (85% know it is the inability of the body to respond to its own insulin), the number of patients that it affects is being greatly underestimated.
A sharp drop in stress hormones after giving birth to a child may predispose some women to develop certain conditions in which the immune system attacks the body's own tissues.
Dana-Farber Cancer Institute researchers have discovered the long-sought molecular "switch" that regulates the liver’s production of glucose.
World-first research at the University of Otago in New Zealand could help reverse the world-wide epidemic of diabetes and significantly reduce heart disease. Results show a 20% improvement in the body’s ability to use insulin.
According to a new study, behavioral changes and improved preventive measures are required to rein in poorly controlled blood sugar and cholesterol in African Americans with diabetes.
Research at Georgetown University Medical Center has found that a combination of naturally occurring edible oils may be effective in treating Type II diabetes.
The Mouse Models of Diabetic Complications Consortium group at Duke University Medical Center has received a five-year grant totaling more than $3.5 million from the NIH to create new mouse models for diabetic kidney and heart disease.
An age-old drug may point to a brand new way to treat type 2 diabetes, according to scientists at Joslin Diabetes Center and the University of California in San Diego (UCSD).
The number of Americans who are hospitalized for stroke continues to increase, but the death rate is declining, according to a recent report.
Geron Corp. announced the publication on Monday of research demonstrating a way to grow human embryonic stem cells without using feeder cells from mice.
The FDA has approved the Premarket Approval Application for Dermagraft in the treatment of chronic foot ulcers in patients with diabetes.
FDA announces a voluntary recall of Micronase lots, Glyburide Tablets
Researchers at the Technion-Israel Institute of Technology have demonstrated that human embryonic stem cells can create insulin producing cells, a result that could signal an important step toward a cure for type 1 diabetes.